Zsuzsa Cselkó

Zsuzsa Cselkó


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in Pathology and Oncology Research
Verified
Journal Article
Open access
PDF file
KBKrisztina Bogos
Krisztina Bogos
ZKZoltan Kiss
Zoltan Kiss
AFAnna Kerpel Fronius
Anna Kerpel Fronius
GTGabriella Temesi
Gabriella Temesi
JEJenő Elek
Jenő Elek
Judit MoldvayJudit Moldvay
Judit Moldvay
Objective:This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region.Methods:Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016–2019 reference period in European countries.Results:Cumulate weekly excess mortality in Hungary was in the negative range until week 44. By week 52, it reached 9,998 excess deaths, corresponding to 7.73% cumulative excess mortality vs. 2016–2019 (p-value = 0.030 vs. 2016–2019). In Q1, only Spain and Italy reported excess mortality compared to the reference period. Significant increases in excess mortality were detected between weeks 13 and 26 in Spain, United Kingdom, Belgium, Netherland and Sweden. Romania and Portugal showed the largest increases in age-standardized cumulative excess mortality in the Q3. The majority of Central and Eastern European countries experienced an outstandingly high impact of the pandemic in Q4 in terms of excess deaths. Hungary ranked 11th in cumulative excess mortality based on the latest available data of from the EUROSTAT database.Conclusion:Hungary experienced a mortality deficit in the first half of 2020 compared to previous years, which was followed by an increase in mortality during the second wave of the COVID-19 pandemic, reaching 7.7% cumulative excess mortality by the end of 2020. The excess was lower than in neighboring countries with similar dynamics of the pandemic.

15 November 2023 in Tobacco Induced Diseases
Verified
Journal Article
Open access
Adrián González-MarrónAdrián González-Marrón
Adrián González-Marrón
HKHelena Koprivnikar
Helena Koprivnikar
JTJudit Tisza
Judit Tisza
ZCZsuzsa Cselkó
Zsuzsa Cselkó
ALAngeliki Lambrou
Angeliki Lambrou
HOHanna Ollila
Hanna Ollila
Introduction: To assess the feasibility of developing World Health Organization (WHO) European Region countries’ goals and measures in line with tobacco endgame objectives, information on the current tobacco control context and capacity is needed. The aim of this study was to assess the...

12 August 2024 in Tobacco Prevention & Cessation
Verified
Journal Article
Open access
ZCZsuzsa Cselkó
Zsuzsa Cselkó
JTJudit Tisza
Judit Tisza
MFMárta Fényes
Márta Fényes
Tobacco use remains the largest preventable cause of death worldwide, including Hungary with a smoking-related death rate in 2019 of 360/100000 (agestandardized death rate), among the highest in the World Health Organization (WHO) European Region. Despite the well-formulated tobacco control...

16 May 2024 in Tobacco Prevention & Cessation
Verified
Journal Article
Open access
RSRenata Solimini
Renata Solimini
HOHanna Ollila
Hanna Ollila
Silvano GallusSilvano Gallus
Silvano Gallus
AHAnne Havermans
Anne Havermans
RTReinskje Talhout
Reinskje Talhout
FOFrances O'DOnovan-Sadat
Frances O'DOnovan-Sadat

12 July 2023 in Tobacco Prevention & Cessation
Verified
Journal Article
Open access
RSRenata Solimini
Renata Solimini
OROtto Ruokolainen
Otto Ruokolainen
ZCZsuzsa Cselkó
Zsuzsa Cselkó
HKHelena Koprivnikar
Helena Koprivnikar
LSLorenzo Spizzichino
Lorenzo Spizzichino
HOHanna Ollila
Hanna Ollila
Nicotine dependence is increasing worldwide due to a wide variety of new and emerging products (e.g. heated tobacco products, electronic cigarettes, nicotine pouches, novel herbal products) with tobacco and/or nicotine content, being continuously placed on the market, including online stores....

16 June 2024 in Orvosi Hetilap
Verified
Journal Article
Open access
PDF file
ZCZsuzsa Cselkó
Zsuzsa Cselkó
AHAdrien Halász
Adrien Halász
IGIstván Gaudi
István Gaudi
IZIstván Zsarnóczay
István Zsarnóczay
KBKrisztina Bogos
Krisztina Bogos
A betegségregiszter olyan, népességre vonatkozó nyilvántartási rendszer, amelynek célja, hogy demográfiai és klinikai információk gyűjtésével, elemzésével, hasznosításával segítse az egészségügyi ellátás minőségének javítását. A magyarországi betegségregiszterek létrehozását és működtetését a 49/2018. számú EMMI rendelet szabályozza. Az Országos Korányi Pulmonológiai Intézet eddig alkalmazott, saját fejlesztésű online adatgyűjtő rendszerei – főként a 2010 óta működő Tuberkulózis Surveillance Rendszer – számottevő tapasztalatot eredményeztek a betegségregiszterek kifejlesztése és üzemeltetése terén. E tapasztalatra építve jött létre 2022-ben a Nemzeti Cisztás Fibrózis Regiszter. A közlemény célja, hogy bemutassa az Országos Korányi Pulmonológiai Intézetben működő Nemzeti Cisztás Fibrózis Regiszter és Tuberkulózis Surveillance Rendszer funkcióját és eredményeit. Orv Hetil. 2024; 165(24–25): 965–972.